Target intelligence / Profile preview

Ribosomal RNA and other cellular RNA (rRNA/RNA)

Target
rRNA/RNA
Molecular classification
Nucleic acid, Ribonucleic acid, Other
01

Overview

Ribosomal RNA (rRNA) and other cellular RNAs are essential nucleic acids that govern the flow of genetic information from DNA to proteins. rRNA serves as the primary structural and catalytic component of the ribosome, facilitating the translation of messenger RNA (mRNA) into polypeptide chains (NIH: Ribosomes and Protein Synthesis). Other RNA types, including transfer RNA (tRNA) and small nuclear RNA (snRNA), are vital for amino acid delivery and mRNA processing, respectively. These molecules are classic targets for antimicrobial therapy, where antibiotics like macrolides and aminoglycosides exploit structural differences between prokaryotic and eukaryotic ribosomes to selectively inhibit bacterial growth (PubMed: PMC3536663). Furthermore, the development of RNA-targeted therapies, such as antisense oligonucleotides and siRNAs, has expanded the therapeutic landscape to include the direct modulation of disease-associated mRNA and non-coding RNAs in human cells (Nature Reviews Drug Discovery: 19, 673–694). This broad category of targets is fundamental to cellular life, and its disruption can lead to cell death or the correction of genetic defects. However, the lack of specificity in this target definition often requires further sub-classification into specific bacterial or human RNA species for drug development purposes.

Other names
rRNAmRNAtRNAncRNARibonucleic acidMessenger RNATransfer RNANon-coding RNA
02

Mechanism of action

Inhibition of the 30S ribosomal subunit, inhibition of the 50S ribosomal subunit, RNA interference (RNAi) mediated degradation of mRNA, and splice-switching modulation via antisense oligonucleotides (StatPearls: Aminoglycosides; PubMed: PMC4812394).

03

Biological functions

Protein synthesisTranslationGene expression regulationCatalysisSplicingOther
04

Disease associations

InfectionCancerGenetic disorderInflammationOther
05

Safety considerations

OtotoxicityNephrotoxicityMitochondrial toxicityOff-target gene silencingImmunogenicity of RNA-based drugsInfusion-related reactions
06

Interacting drugs

Gentamicin

9 more in the full profile.

07

Biomarkers

RNA expression levels16S rRNA sequencingSpecific RNA mutationsRNA integrity number (RIN)

Beyond the preview

Go deeper on Ribosomal RNA and other cellular RNA (rRNA/RNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal RNA and other cellular RNA (rRNA/RNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call